Initial Testing (Stage 1) of Lapatinib by the Pediatric Preclinical Testing Program

BACKGROUND: Lapatinib is a small molecule reversible tyrosine kinase inhibitor of EGFR and ErbB2 that shows in vitro and in vivo activity against a range of EGFR and ErbB2-dependent adult cancer cell lines and that has clinical efficacy against ErbB2-overexpressing breast cancer. METHODS: Lapatinib...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gorlick, Richard, Kolb, E. Anders, Houghton, Peter J., Morton, Christopher L., Phelps, Doris, Schaiquevich, Paula, Stewart, Clinton, Keir, Stephen T., Lock, Richard, Carol, Hernan, Reynolds, C. Patrick, Maris, John M., Wu, Jianrong, Smith, Malcolm A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2009
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2731000/
https://ncbi.nlm.nih.gov/pubmed/19554571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.21989
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge